XML 21 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2024
Mar. 26, 2023
Mar. 31, 2024
Mar. 26, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:        
Net income $ 965,826 $ 814,008 $ 2,807,490 $ 3,708,394
Adjustments to reconcile net income to net cash provided by operating activities:        
Depreciation and amortization     271,342 252,828
Deferred income taxes     (137,606) (133,101)
Equity-based compensation expense 76,854 73,911 213,966 218,105
Other, net     14,242 11,537
Changes in operating assets and liabilities     620,405 (1,550)
Net cash provided by operating activities     3,789,839 4,056,213
CASH FLOWS FROM INVESTING ACTIVITIES:        
Capital expenditures and intangible assets     (295,922) (422,898)
Business acquisitions, net of cash acquired     0 (119,955)
Proceeds from maturities of available-for-sales securities     34,336 65,015
Proceeds from sales of available-for-sale securities     3,430 6,837
Other, net     (10,845) (8,381)
Net cash used for investing activities     (269,001) (479,382)
CASH FLOWS FROM FINANCING ACTIVITIES:        
Principal payments on debt, including finance lease obligations     (255,155) (21,145)
Treasury stock purchases     (2,469,257) (1,147,998)
Dividends paid     (757,453) (675,572)
Reissuance of treasury stock related to employee stock purchase plan     53,081 44,996
Proceeds from issuance of common stock     12,757 7,673
Other, net     (5,672) (635)
Net cash used for financing activities     (3,421,699) (1,792,681)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash     (12,758) (1,349)
Net change in cash, cash equivalents, and restricted cash     86,381 1,782,801
Cash, cash equivalents, and restricted cash at beginning of period [1]     5,587,372 3,773,535
Cash, cash equivalents, and restricted cash at end of period [1] 5,673,753 5,556,336 5,673,753 5,556,336
Schedule of non-cash transactions:        
Accrued payables for stock repurchases, including applicable excise tax     36,863 4,081
Accrued payables for capital expenditures     45,122 38,225
Dividends payable 261,463 233,043 261,463 233,043
Transfers of finished goods inventory to property and equipment     55,290 64,932
Reconciliation of cash, cash equivalents, and restricted cash        
Cash and cash equivalents 5,672,232 5,305,648 5,672,232 5,305,648
Restricted cash and cash equivalents [1] 1,521 250,688 1,521 250,688
Total cash, cash equivalents, and restricted cash [1] $ 5,673,753 $ 5,556,336 $ 5,673,753 $ 5,556,336
[1] Restricted cash is reported within Other assets in the Condensed Consolidated Balance Sheets